» Articles » PMID: 33967572

Making Choices: DNA Replication Fork Recovery Mechanisms

Overview
Date 2021 May 10
PMID 33967572
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

DNA replication is laden with obstacles that slow, stall, collapse, and break DNA replication forks. At each obstacle, there is a decision to be made whether to bypass the lesion, repair or restart the damaged fork, or to protect stalled forks from further demise. Each "decision" draws upon multitude of proteins participating in various mechanisms that allow repair and restart of replication forks. Specific functions for many of these proteins have been described and an understanding of how they come together in supporting replication forks is starting to emerge. Many questions, however, remain regarding selection of the mechanisms that enable faithful genome duplication and how "normal" intermediates in these mechanisms are sometimes funneled into "rogue" processes that destabilize the genome and lead to cancer, cell death, and emergence of chemotherapeutic resistance. In this review we will discuss molecular mechanisms of DNA damage bypass and replication fork protection and repair. We will specifically focus on the key players that define which mechanism is employed including: PCNA and its control by posttranslational modifications, translesion synthesis DNA polymerases, molecular motors that catalyze reversal of stalled replication forks, proteins that antagonize fork reversal and protect reversed forks from nucleolytic degradation, and the machinery of homologous recombination that helps to reestablish broken forks. We will also discuss risks to genome integrity inherent in each of these mechanisms.

Citing Articles

Prime Editing: Mechanistic Insights and DNA Repair Modulation.

Mentani A, Maresca M, Shiriaeva A Cells. 2025; 14(4).

PMID: 39996750 PMC: 11853414. DOI: 10.3390/cells14040277.


DNA polymerase zeta can efficiently replicate structures formed by AT/TA repeat sequences and prevent their deletion.

Das M, Hile S, Brewster J, Boer J, Bezalel-Buch R, Guo Q Nucleic Acids Res. 2024; 53(3).

PMID: 39727171 PMC: 11797062. DOI: 10.1093/nar/gkae1254.


Molecular mechanism of PARP inhibitor resistance.

Huang Y, Chen S, Yao N, Lin S, Zhang J, Xu C Oncoscience. 2024; 11:69-91.

PMID: 39318358 PMC: 11420906. DOI: 10.18632/oncoscience.610.


Combined inhibition of RAD51 and CHK1 causes synergistic toxicity in cisplatin resistant cancer cells by triggering replication fork collapse.

Mann J, Niedermayer K, Krautstrunk J, Abbey L, Wiesmuller L, Piekorz R Int J Cancer. 2024; 156(2):389-402.

PMID: 39239809 PMC: 11578078. DOI: 10.1002/ijc.35164.


Helicase HELQ: Molecular Characters Fit for DSB Repair Function.

Zhao Y, Hou K, Liu Y, Na Y, Li C, Luo H Int J Mol Sci. 2024; 25(16).

PMID: 39201320 PMC: 11355030. DOI: 10.3390/ijms25168634.


References
1.
Fan Q, Xu X, Zhao X, Wang Q, Xiao W, Guo Y . Rad5 coordinates translesion DNA synthesis pathway by recognizing specific DNA structures in saccharomyces cerevisiae. Curr Genet. 2018; 64(4):889-899. DOI: 10.1007/s00294-018-0807-y. View

2.
Gangavarapu V, Haracska L, Unk I, Johnson R, Prakash S, Prakash L . Mms2-Ubc13-dependent and -independent roles of Rad5 ubiquitin ligase in postreplication repair and translesion DNA synthesis in Saccharomyces cerevisiae. Mol Cell Biol. 2006; 26(20):7783-90. PMC: 1636848. DOI: 10.1128/MCB.01260-06. View

3.
Mijic S, Zellweger R, Chappidi N, Berti M, Jacobs K, Mutreja K . Replication fork reversal triggers fork degradation in BRCA2-defective cells. Nat Commun. 2017; 8(1):859. PMC: 5643541. DOI: 10.1038/s41467-017-01164-5. View

4.
Jeong Y, Rossi M, Cermak L, Saraf A, Florens L, Washburn M . FBH1 promotes DNA double-strand breakage and apoptosis in response to DNA replication stress. J Cell Biol. 2013; 200(2):141-9. PMC: 3549964. DOI: 10.1083/jcb.201209002. View

5.
Masuda-Ozawa T, Hoang T, Seo Y, Chen L, Spies M . Single-molecule sorting reveals how ubiquitylation affects substrate recognition and activities of FBH1 helicase. Nucleic Acids Res. 2013; 41(6):3576-87. PMC: 3616717. DOI: 10.1093/nar/gkt056. View